NCT05818839 is a clinical trial in Cerebral Palsy, sponsored by Ilke KARA.

Who is sponsoring NCT05818839?

NCT05818839 is sponsored by Ilke KARA.

What condition does NCT05818839 study?

NCT05818839 studies Cerebral Palsy.

Is NCT05818839 still recruiting?

NCT05818839 is currently completed. Last updated 19 April 2023.

Last reviewed 2023-04-19 · How we verify

NCT05818839

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biomechanical Properties and Their Association With Balance and Functional Mobility in Children With Cerebral Palsy

Completed Last updated 19 April 2023

What this trial tests

trial in Cerebral Palsy in 80 participants. Completed in 20 February 2023.

Timeline

1 July 2022

Primary endpoint
20 November 2022

20 February 2023

Quick facts

Lead sponsor	Ilke KARA
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 July 2022
Primary completion	20 November 2022
Estimated completion	20 February 2023
Sites	1 location across Turkey (Türkiye)

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Ilke KARA — full company profile →

Who can join

Adults 4 to 12, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the differences in the biomechanical properties of the dorsal trunk and lower extremity muscles of children with unilateral spastic cerebral palsy compared with their typically developing peers, and the effect of these biomechanical properties on balance and functional mobility performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Ilke KARA trials

Trials by the same sponsor.

NCT05970692 — Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale · unknown
NCT06004635 — Reliability of Myotonometry in the Assessment of Mechanical Properties of Thenar Muscles · completed
NCT06518811 — The Effect of Telerehabilitation on Pain, Physical and Biopsychosocial Factors in Parent Carers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05818839 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ilke KARA
Last refreshed: 19 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05818839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing